LPL Financial
SRNE

LPL Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

LPL Financial’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-108,865
Closed -$96.5K – 4658
2022
Q4 		$96.5K Sell
108,865
-5,238
-5% -$6.95K ﹤0.01% 4175
2022
Q3 		$179K Sell
114,103
-2,447
-2% -$5.55K ﹤0.01% 3981
2022
Q2 		$234K Buy
116,550
+8,146
+8% +$14.1K ﹤0.01% 3826
2022
Q1 		$253K Buy
108,404
+23,871
+28% +$74.5K ﹤0.01% 3700
2021
Q4 		$393K Sell
84,533
-27,200
-24% -$169K ﹤0.01% 3483
2021
Q3 		$853K Sell
111,733
-2,578
-2% -$21.9K ﹤0.01% 2748
2021
Q2 		$1.11M Buy
114,311
+14,167
+14% +$113K ﹤0.01% 2478
2021
Q1 		$828K Sell
100,144
-79,603
-44% -$841K ﹤0.01% 2564
2020
Q4 		$1.23M Buy
179,747
+7,771
+5% +$62.4K ﹤0.01% 2030
2020
Q3 		$1.92M Sell
171,976
-109,070
-39% -$998K ﹤0.01% 1483
2020
Q2 		$1.76M Buy
281,046
+265,436
+1,700% +$1.02M ﹤0.01% 1423
2020
Q1 		$29K Buy
+15,610
New +$45K ﹤0.01% 3124

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

LPL Financial's SRNE Position: Q1 2023 in Review

LPL Financial sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 108,865 shares — an estimated $96.5K sold.

LPL Financial first reported a position in SRNE in Q1 2020 and held it in 12 quarters. The position peaked at $1.92M in Q3 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • LPL Financial reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • LPL Financial sold 108,865 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $96.5K.
  • LPL Financial first reported a position in Sorrento Therapeutics, Inc. in Q1 2020 and held it in 12 quarters.
  • LPL Financial's Sorrento Therapeutics, Inc. position peaked at $1.92M in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on LPL Financial's 13F filing for Q1 2023, filed 10 May 2023.